Drug therapy for lower urinary tract dysfunction.
D001626:Bethanechol Compounds / Q000627:therapeutic use; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D001743:Urinary Bladder / Q000033:anatomy & histology / Q000502:physiology / Q000503:physiopathology; D001745:Urinary Bladder Diseases / Q000188:drug therapy*
D001626:Bethanechol Compounds; D010276:Parasympatholytics; D010643:Phenoxybenzamine; D010665:Phenylpropanolamine; D004809:Ephedrine